本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cartesian Therapeutics

6.57
-0.4200-6.01%
盘后:6.570.00000.00%19:30 EDT
成交量:21.86万
成交额:144.60万
市值:1.99亿
市盈率:-1.13
高:7.02
开:6.98
低:6.57
收:6.99
52周最高:11.00
52周最低:5.60
股本:3,025.54万
流通股本:1,240.27万
量比:1.57
换手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-5.7983
每股收益(LYR):-5.0200
净资产收益率:-7029.26%
总资产收益率:-17.43%
市净率:-1.59
市盈率(LYR):-1.31

数据加载中...

2025/01/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans